216 related articles for article (PubMed ID: 15123502)
1. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions.
Chisholm D; Sanderson K; Ayuso-Mateos JL; Saxena S
Br J Psychiatry; 2004 May; 184():393-403. PubMed ID: 15123502
[TBL] [Abstract][Full Text] [Related]
2. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis.
Chisholm D; Rehm J; Van Ommeren M; Monteiro M
J Stud Alcohol; 2004 Nov; 65(6):782-93. PubMed ID: 15700517
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
Chisholm D;
Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.
Katon W; Unützer J; Fan MY; Williams JW; Schoenbaum M; Lin EH; Hunkeler EM
Diabetes Care; 2006 Feb; 29(2):265-70. PubMed ID: 16443871
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of collaborative care for depression in a primary care veteran population.
Liu CF; Hedrick SC; Chaney EF; Heagerty P; Felker B; Hasenberg N; Fihn S; Katon W
Psychiatr Serv; 2003 May; 54(5):698-704. PubMed ID: 12719501
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.
Simon GE; Katon WJ; VonKorff M; Unützer J; Lin EH; Walker EA; Bush T; Rutter C; Ludman E
Am J Psychiatry; 2001 Oct; 158(10):1638-44. PubMed ID: 11578996
[TBL] [Abstract][Full Text] [Related]
9. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder.
Chisholm D; van Ommeren M; Ayuso-Mateos JL; Saxena S
Br J Psychiatry; 2005 Dec; 187():559-67. PubMed ID: 16319409
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial.
Schoenbaum M; Unützer J; Sherbourne C; Duan N; Rubenstein LV; Miranda J; Meredith LS; Carney MF; Wells K
JAMA; 2001 Sep; 286(11):1325-30. PubMed ID: 11560537
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
[TBL] [Abstract][Full Text] [Related]
13. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
14. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
[TBL] [Abstract][Full Text] [Related]
15. Economic costs of antidepressant use: a population-based study in Sweden.
Beckman L; von Kobyletzki L; Svensson M
J Ment Health Policy Econ; 2019 Dec; 22(4):125-130. PubMed ID: 32058977
[TBL] [Abstract][Full Text] [Related]
16. [The costs of depression and the cost-effectiveness of treatment].
König HH; Luppa M; Riedel-Heller S
Psychiatr Prax; 2010 Jul; 37(5):213-5. PubMed ID: 20597034
[No Abstract] [Full Text] [Related]
17. Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care.
Johnson JA; Lier DA; Soprovich A; Al Sayah F; Qiu W; Majumdar SR
Am J Prev Med; 2016 Jul; 51(1):e13-20. PubMed ID: 26947212
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings.
Dziekan G; Chisholm D; Johns B; Rovira J; Hutin YJ
Bull World Health Organ; 2003; 81(4):277-85. PubMed ID: 12764494
[TBL] [Abstract][Full Text] [Related]
19. The costs and benefits of enhanced depression care to employers.
Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
[TBL] [Abstract][Full Text] [Related]
20. The burden of disease for treatment-resistant depression.
Greden JF
J Clin Psychiatry; 2001; 62 Suppl 16():26-31. PubMed ID: 11480881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
